N.A. Shevkunova (1), M.V. Vorobyov (2), V.V. Gushchin (2)
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
|
№4 / 2021
|
M.B. Antsiferov (1), A.V. Zilov (2), O.M. Koteshkova (1), N.A. Demidov (3)
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
|
№4 / 2021
|
A.S. Ametov (1), E.A. Tertychnaya (2)
Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance
|
№14 / 2019
|
T.N. Markova (1, 2)
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
|
№4 / 2019
|
E.V. Biryukova, I.V. Solovyova
Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?
|
№4 / 2019
|
L.A. Sharonova, A.F. Verbovoy
The place of glyflozins in the management of type 2 diabetes mellitus
|
№4 / 2019
|
A.P. Pereverzev, O.D. Ostroumova, O.N. Tkacheva
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
|
№4 / 2019
|
K.V. Antonova (1), M.M. Tanashyan (1), M.Yu. Maksimova (1), N.V. Shakhparonova (1), T.I. Romantsova (2)
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
|
№4 / 2019
|
G.I. Izhbuldina (1), L.B. Novikova (2)
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
|
№4 / 2019
|
M.B. Antsiferov (1), B.B. Kvasnikov (2)
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
|
№4 / 2019
|
I.G. Tsvetkova (1), A.N. Kaukova (2), N.A. Belyakova (1), O.A. Vasyutkova (2), O.V. Konovalova (2), A.V. Lareva (1)
DISTURBANCES OF THE AUTONOMIC INNERVATION OF THE CARDIOVASCULAR SYSTEM AND HEMOSTASIS: THEIR ROLE IN THE CHANGE OF MICROCIRCULATION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№16 / 2017
|
O.S. Elsukova, A.A. Sobolev
ADVANTAGES OF SWITCH TO PREMIXED INSULIN DEGLUDEC/ ASPART IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WHO HAVE NOT ACHIEVED AN OPTIMAL CONTROL WITH PREVIOUS INSULIN THERAPY
|
№16 / 2017
|